(Q31089499)

English

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

scientific article

Statements

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized (English)
Vicente Valero
Nuhad K Ibrahim
Deborah Francis
Kristine R Broglio
Richard L Theriault
Lajos Pusztai
Marjorie C Green
Aysegul A Sahin
Francisco Esteva
William F Symmans
Michael S Ewer
Thomas A Buchholz

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit